Electroconvulsive therapy requires higher dosage levels: Food and Drug Administration action is required.
Abrams
R
R
Department of Psychiatry and Behavioral Sciences, Chicago Medical School, North Chicago, IL 60064, USA.
D000647:Amnesia / Q000209:etiology; D003072:Cognition Disorders / Q000209:etiology; D003866:Depressive Disorder / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence* / Q000379:methods; D007839:Functional Laterality; D006801:Humans; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration